LIPERTANCE 20MG/10MG/5 MG TBL FLM 30
Rychlý přehled
| Dosage form | Tablets film-coated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 226,98 Kč. Maximální cena: 370,11 Kč. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Vápenatá sůl atorvastatinu (21,64 mg), atorvastatin (20 mg), perindopril-arginin (10 mg), perindopril (6,79 mg), amlodipin-besilát (6,94 mg), amlodipin (5 mg), monohydrát laktosy, uhličitan vápenatý, hyprolosa, sodná sů… |
| Dostupnost / výpadek | Výpadek The latest report from the manufacturer is from 30. 6. 2026. Výroba byla přerušena od 1. 9. 2026. The stated reason was: Výrobní důvody. Resumption of supply is expected 1. 10. 2026Výrobce jako potenciální náhradu uvádí léky s kód… |
| Kód SÚKL | 0205998 |
What is the maximum co-payment for LIPERTANCE?
If the insurance company contributes, the maximum co-payment is 226,98 Kč. The maximum pharmacy price is 370,11 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does LIPERTANCE have a counted co-payment set?
Yes, the medicine has a counted co-payment of 213,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
143,13 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe LIPERTANCE?
Prescription is not conditional on a medical specialization.
What is the composition of LIPERTANCE?
Vápenatá sůl atorvastatinu (21,64 mg), atorvastatin (20 mg), perindopril-arginin (10 mg), perindopril (6,79 mg), amlodipin-besilát (6,94 mg), amlodipin (5 mg), monohydrát laktosy, uhličitan vápenatý, hyprolosa, sodná sůl karboxymethylškrobu (typ a), mikrokrystalická celulosa, maltodextrin, magnesium-stearát, glycerol, hypromelosa, makrogol 6000, oxid titaničitý, žlutý oxid železitý. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to LIPERTANCE?
The medicine belongs to ATC group C10BX11 – . Medicines with the same active substance can be found here.
Who manufactures LIPERTANCE?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 30. 6. 2026. Production was interrupted as of 1. 9. 2026. The stated reason was: Výrobní důvody.
Resumption of supply is expected 1. 10. 2026
The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for LIPERTANCE?
The medicine has code 0205998. Code details can be found here.
How many packs of LIPERTANCE were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of LIPERTANCE were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026